Tuberculosis (TB) has always been a challenge for clinicians and researchers.A lot have been done for its management and lot more is awaited.Diagnosing TB became faster with the advent and validation of Xpert ® MTB/RIF (GeneXpert MTB/RIF or Xpert) and improvements over these instruments are coming to help to resolve bottlenecks.Similarly, better drugs with shorter treatment durations are long awaited and there has been some progress on this front too.This short review discusses recent advances from these fields.
No takes yet. Share an insight, caveat, or question.
Vijay Nema (2017) studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: